125 related articles for article (PubMed ID: 2644144)
1. Effect of cyclosporin on interleukin 2-related T-lymphocyte parameters in IDDM patients.
Chatenoud L; Feutren G; Nelson DL; Boitard C; Bach JF
Diabetes; 1989 Feb; 38(2):249-56. PubMed ID: 2644144
[TBL] [Abstract][Full Text] [Related]
2. Aberrant distribution of CD4 and CD8 lymphocyte subsets in recent-onset IDDM patients. Effect of cyclosporin.
Chatenoud L; Volpini W; Timsit J; Boitard C; Bach JF
Diabetes; 1993 Jun; 42(6):869-75. PubMed ID: 7684344
[TBL] [Abstract][Full Text] [Related]
3. Imbalance of the interleukin 2 system in children with IDDM.
Tomoda T; Kurashige T; Taniguchi T
Diabetologia; 1994 May; 37(5):476-82. PubMed ID: 8056185
[TBL] [Abstract][Full Text] [Related]
4. Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type I diabetes mellitus.
al-Kassab AS; Raziuddin S
Clin Exp Immunol; 1990 Aug; 81(2):267-71. PubMed ID: 1696864
[TBL] [Abstract][Full Text] [Related]
5. In vitro secretion of interleukin 2 and expression of IL-2 receptor in peripheral blood lymphocytes in high risk of insulin-dependent diabetes mellitus subjects.
Kretowski A; Myśliwiec J; Szelachowska M; Brzozowski C; Pietruczuk M; Kinalska I
Arch Immunol Ther Exp (Warsz); 1999; 47(1):45-9. PubMed ID: 11729828
[TBL] [Abstract][Full Text] [Related]
6. The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+.
De Berardinis P; Londei M; Kahan M; Balsano F; Kontiainen S; Gale EA; Bottazzo GF; Feldmann M
Clin Exp Immunol; 1988 Aug; 73(2):255-9. PubMed ID: 2972427
[TBL] [Abstract][Full Text] [Related]
7. Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus.
Kasaian MT; Biron CA
J Immunol; 1990 Jan; 144(1):299-306. PubMed ID: 1967265
[TBL] [Abstract][Full Text] [Related]
8. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
Gessl A; Waldhäusl W
J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
[TBL] [Abstract][Full Text] [Related]
9. Clinical trials of cyclosporin in IDDM.
Dupré J; Stiller CR; Gent M; Donner A; von Graffenried B; Heinrichs D; Jenner M; Keown P; Mahon J; Martell R
Diabetes Care; 1988; 11 Suppl 1():37-44. PubMed ID: 3069390
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
[TBL] [Abstract][Full Text] [Related]
11. Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patients.
Calder VL; Bellamy AS; Owen S; Lewis C; Rudge P; Davison AN; Feldmann M
Clin Exp Immunol; 1987 Dec; 70(3):570-7. PubMed ID: 3124996
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive effects of cyclosporin A on cloned T cells.
Herold KC; Lancki DW; Moldwin RL; Fitch FW
J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism of immunosuppression mediated by ethanol.
Kaplan DR
Cell Immunol; 1986 Oct; 102(1):1-9. PubMed ID: 3100053
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo action of cyclosporin A on the induction of human interleukin-2 receptor alpha and beta chains.
Caillat-Zucman S; Chatenoud L; Bach JF
Clin Exp Immunol; 1989 Aug; 77(2):184-90. PubMed ID: 2789115
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of CD4+ T lymphocyte proliferative responses from patients with recently diagnosed insulin-dependent diabetes mellitus.
al-Kassab AS; Raziuddin S
Diabetes Res Clin Pract; 1990; 10(1):45-9. PubMed ID: 2123429
[TBL] [Abstract][Full Text] [Related]
16. Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus.
Petersen LD; Duinkerken G; Bruining GJ; van Lier RA; de Vries RR; Roep BO
J Autoimmun; 1996 Dec; 9(6):731-7. PubMed ID: 9115575
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclosporin A upon humoral and cellular immune parameters in insulin-dependent diabetes mellitus type I: a long-term follow-up study.
Müller C; Zielinski CC; Kalinowski W; Wolf H; Mannhalter JW; Aschauer-Treiber G; Klösch-Kasparek D; Gaube S; Eibl MM; Schernthaner G
J Endocrinol; 1989 Apr; 121(1):177-83. PubMed ID: 2654321
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes.
Ilonen J; Surcel HM; Käär ML
Clin Exp Immunol; 1991 Aug; 85(2):278-81. PubMed ID: 1677834
[TBL] [Abstract][Full Text] [Related]
19. In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A.
Granelli-Piperno A
J Exp Med; 1988 Nov; 168(5):1649-58. PubMed ID: 2903210
[TBL] [Abstract][Full Text] [Related]
20. Constitutive impaired TCR/CD3-mediated activation of T cells in IDDM patients co-exist with normal co-stimulation pathways.
Nervi S; Atlan-Gepner C; Fossat C; Vialettes B
J Autoimmun; 1999 Sep; 13(2):247-55. PubMed ID: 10479393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
